Camptothecin encapsulated into functionalized MCM-41: In vitro release study, cytotoxicity and kinetics.

Mater Sci Eng C Mater Biol Appl

Department of Chemistry, Faculty of Science, The Maharaja Sayajirao University of Baroda, Vadodara 390002, Gujarat, India. Electronic address:

Published: May 2019


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The application of MCM-41 functionalized by 12-tungstophosphoric acid (TPA) as drug carrier for cancer treatment was studied by loading of camptothecin (CPT). In-vitro controlled release study of CPT in Simulated Body Fluid (pH 7.4, 37 °C) was carried out under stirring as well as static conditions. The systems were also evaluated on cancer cells (HepG2) and the carriers are found to be non-toxic to the cancer cells. In order to see the influence of inorganic moiety on release rate of drug, study was also carried out with CPT loaded unfunctionalized MCM-41. A detailed study on release kinetics and release mechanism using First Order Release Kinetic Model, Higuchi Model, Koresmeyer-Pepps Model and Extended kinetic model was also carried out.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msec.2019.01.065DOI Listing

Publication Analysis

Top Keywords

release study
8
cancer cells
8
kinetic model
8
release
6
camptothecin encapsulated
4
encapsulated functionalized
4
functionalized mcm-41
4
mcm-41 vitro
4
vitro release
4
study
4

Similar Publications

Patients with traumatic injuries who develop ventilator-associated pneumonia (VAP) incur a higher risk of developing multi-drug resistance. Shorter duration of antibiotic agents for early VAP at five days may reduce antibiotic agent exposure without worsening patient outcomes. This retrospective cohort study performed at a Level I Trauma Center included adult (≥16 years old) patients with trauma diagnosed with bronchoalveolar lavage (BAL)-proven early (within four days of intubation) bacterial VAP.

View Article and Find Full Text PDF

Patients with complex care needs present numerous challenges: the care they receive is often associated with more hospital admissions. The care provided to this group could benefit from being more goal-oriented and better integrated. However, strengthening a net-work of care for these patients starting from hospitalization remains a challenge.

View Article and Find Full Text PDF

Microglia, the resident immune cells of the central nervous system (CNS), are involved in the pathogenesis of neurodegenerative diseases, such as Alzheimer's disease (AD), Dementia with Lewy Bodies (DLB), and Parkinson's disease (PD). 14-3-3 proteins act as molecular hubs to regulate protein-protein interactions, which are involved in numerous cellular functions, including cellular signaling, protein folding, and apoptosis. We previously revealed decreased 14-3-3 levels in the brains of human subjects with neurodegenerative diseases.

View Article and Find Full Text PDF

Covalently Supported Phenazine for Electrochemical Capture of Low Concentration CO.

ACS Appl Mater Interfaces

September 2025

School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, P. R. China.

Electrochemical CO capture (eCC) excels in selectivity, reversibility, low-temperature operation, and reusability, yet liquid-phase systems struggle with mass transfer limitations. In this study, a phenazine-based capture agent was chemically grafted onto carboxylated carbon nanotubes, achieving an active loading of 4.4 wt %.

View Article and Find Full Text PDF

Objective: One of the most frequent neuropsychiatric complications after a stroke is poststroke depression (PSD). However, it is unclear whether disparities exist in PSD diagnosis. The authors examined a 10-year trend in PSD by socioeconomic and clinical characteristics.

View Article and Find Full Text PDF